Resources

COVID-19 Post-Vaccine Risks, Activities, and Public Health Measures

Product: — Evidence Synthesis Network

Public Health Policy Regulation & Policy Vaccine Vaccines & Immunity

esnetwork.ca Last Updated: May 12, 2021

The Impact of Reopening and the Lifting of COVID‑19 Restrictions

Product: — Evidence Synthesis Network

Public Health Policy Re-Opening Regulation & Policy

esnetwork.ca Last Updated: May 12, 2021

Remdesivir for Hospitalized Patients with COVID-19

Product: — Science Table

Drug Interventions Treatments

covid19-sciencetable.ca Last Updated: May 6, 2021

Benefits of Paid Sick Leave During the COVID‑19 Pandemic

Product: — Science Table

Regulation & Policy Workplace Regulations

covid19-sciencetable.ca Last Updated: April 28, 2021

Long COVID‑19 Clinics

Product: — Evidence Synthesis Network

Long Covid Regulation & Policy Workplace Regulations

esnetwork.ca Last Updated: April 27, 2021

Clinical Practice Guidelines Webinar: Tocilizumab

Product: — Science Table

Drug Interventions Healthcare Workers Models Treatments

covid19-sciencetable.ca Last Updated: April 26, 2021

Chloroquine or Hydroxychloroquine to Prevent or Treat COVID-19

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Last Updated: April 26, 2021

Also available in Français

Ongoing Trials for Drugs in the Prevention and Treatment of COVID-19

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Treatments

covid.cadth.ca Last Updated: April 22, 2021

Also available in Français

Fighting COVID‑19 in Ontario: The Way Forward

Product: — Science Table

About Coronavirus Epidemiology Public Health Policy Regulation & Policy

covid19-sciencetable.ca Last Updated: April 20, 2021

Strategies to Manage Tocilizumab Supply During the COVID‑19 Pandemic

Product: — Science Table

Drug Interventions Future Planning Treatments

covid19-sciencetable.ca Last Updated: April 19, 2021